Carrageenan: FDA GRAS Status, IARC Classification & Regulatory Intelligence

What Is Carrageenan?

Carrageenan is a family of sulfated polysaccharides extracted from red seaweed (class Rhodophyceae), used widely as a thickener, stabilizer, and gelling agent in food products. It is a naturally derived hydrocolloid consisting mainly of ammonium, calcium, magnesium, potassium, and sodium sulfate esters of galactose and 3,6-anhydrogalactose polysaccharides.

Property	Value
CAS Number	9000-07-1
UNII	5C69YCD2YJ
E Number	E407 (carrageenan), E407a (processed Eucheuma seaweed)
INS Number	407
Molecular Weight	200-800 kDa (variable by source and extraction)
Sulfate Content	20-40% on dry-weight basis
Source	Red seaweed — Chondrus crispus, Eucheuma spp., Gigartina spp.

Carrageenan is extracted from seaweed by aqueous processing and exists in three principal forms, each with distinct functional properties:

Kappa-carrageenan — One sulfate group per disaccharide unit. Forms firm, brittle gels in the presence of potassium ions. The most commercially significant form, predominant in processed meats, dairy products, and confectionery.

Iota-carrageenan — Two sulfate groups per disaccharide unit. Forms soft, elastic gels in the presence of calcium ions with freeze-thaw stability. Used in salad dressings, soy milk, and pet food gravies.

Lambda-carrageenan — Three sulfate groups per disaccharide unit. Non-gelling; functions exclusively as a thickener. The only form that is cold-soluble without being a sodium salt. Used in dairy beverages, syrups, and sauces.

Blending kappa, iota, and lambda forms enables a broader range of textural and functional properties than any single type achieves alone.

The Critical Distinction: Carrageenan vs. Poligeenan

The single most important regulatory and scientific distinction in this space is between food-grade carrageenan and degraded carrageenan (poligeenan). Nearly all public concern about carrageenan traces back to a conflation of these two substances.

Poligeenan (formerly called "degraded carrageenan" in scientific literature prior to 1988) is a distinctly different substance. It is produced by subjecting carrageenan to extensive acid hydrolysis at low pH and high temperatures for extended periods. The result is a low-viscosity, low-molecular-weight polymer that bears little resemblance to the food-grade ingredient.

The name "poligeenan" was formally adopted by the United States Adopted Names (USAN) Council in 1988 specifically to disambiguate the two substances. Despite this, the older terminology persists in some scientific literature and consumer advocacy materials.

Property	Food-Grade Carrageenan	Poligeenan (Degraded)
Molecular weight	200-800 kDa	<50 kDa
Production	Aqueous extraction from seaweed	Acid hydrolysis of carrageenan
FDA food additive status	Approved (GRAS)	Not approved
IARC classification	Group 3 (not classifiable)	Group 2B (possibly carcinogenic)
Commercial food use	Yes	No

This distinction is not semantic — it is the foundation of every regulatory assessment.

FDA Regulatory Status

Carrageenan holds dual FDA authorization:

21 CFR 172.620 — Carrageenan. The food additive carrageenan may be safely used in food as an emulsifier, stabilizer, or thickener, except for those standardized foods that do not provide for such use. The regulation specifies approved source seaweed species, chemical composition requirements (sulfate content 20-40% dry weight), and permitted functional uses.

21 CFR 182.7255 — Chondrus Extract. Listed as GRAS for use as a stabilizer.

Citizen Petitions

The FDA has received citizen petitions requesting removal of carrageenan and has consistently maintained its GRAS determination:

• 2008: Dr. Joanne Tobacman (University of Illinois-Chicago) filed a citizen petition presenting studies linking carrageenan to gastrointestinal inflammation. FDA denied the petition in June 2012.
• 2013: Richard C. Theuer, a food scientist aligned with the Cornucopia Institute, filed a citizen petition proposing carrageenan be prohibited in infant formula.

Current status: No pending FDA rulemaking, no restrictions, no label requirements specific to carrageenan. Fully approved for food use.

IARC Classification

The IARC classification is the primary driver of public concern. The full picture:

• Volume 31 (1983): Evaluated both native and degraded carrageenan. Degraded carrageenan was tested in rats; colorectal cancers were induced in each study.
• Supplement 7 (1987) — Final Classifications:
  • Native (undegraded) carrageenan: Group 3 — "Not classifiable as to its carcinogenicity to humans." No evidence of carcinogenicity was found in animal studies.
  • Degraded carrageenan (poligeenan): Group 2B — "Possibly carcinogenic to humans." Based on sufficient evidence of carcinogenicity in rats.

The Group 2B classification applies exclusively to poligeenan — a substance that is not approved for food use, is not used in food manufacturing, and is chemically distinct from food-grade carrageenan. The Group 3 classification for food-grade carrageenan is often omitted from consumer advocacy materials.

Key Deadlines

Date	Event	Type
November 25, 2025	EFSA data submission deadline for carrageenan (E407) re-evaluation, including infant formula uses	International
2026	NOSB next sunset review cycle for carrageenan on National List	Federal
2028	Carrageenan organic allowance sunset date (if not renewed)	Federal
Ongoing	EFSA re-evaluation expected to conclude 2026-2027	International

The USDA Organic Carrageenan Wars

The most contentious regulatory battle over carrageenan has played out within the USDA's organic standards framework.

November 2016 — NOSB Votes 10-3 to Remove. The National Organic Standards Board voted decisively to remove carrageenan from the National List, recommending it no longer be permitted in USDA Organic products. This was widely reported as a "ban" in consumer media, though the NOSB's role is advisory — final authority rests with the USDA.

April 2018 — USDA Overrules NOSB. The USDA's Agricultural Marketing Service overruled the NOSB recommendation and renewed carrageenan's organic-approved status, citing "sufficient evidence in public comments that carrageenan continues to be necessary for handling agricultural products because of the unavailability of wholly natural substitutes."

Fall 2021 — NOSB Votes 9-5 to Remove, But Motion Fails. Nine members voted to remove carrageenan, but the vote fell short of the two-thirds supermajority now required to delist items from the National List. Carrageenan was effectively relisted.

2024-2025 — USDA Maintains Approval. Despite the second recommendation, the USDA again reaffirmed carrageenan's status on the National List.

Next review: Carrageenan is up for sunset review again in 2026, with a sunset date of 2028. If ultimately delisted, producers would have a two-year transition period to reformulate.

Scientific Controversy

The Tobacman Research

Dr. Joanne Tobacman at the University of Illinois-Chicago has been the most prominent researcher raising concerns, publishing studies linking both degraded and undegraded carrageenan to gastrointestinal inflammation through mechanisms involving NF-kappaB signaling pathways.

Regulatory Body Responses

Every major regulatory body that has evaluated carrageenan has reviewed this research and maintained approval:

• FDA: Denied the Tobacman citizen petition in 2012, maintaining GRAS status.
• JECFA: Maintained ADI "not specified" through multiple reviews (most recently 2015). An ADI of "not specified" is the most favorable safety classification JECFA assigns.
• EFSA: Concluded intake from food additive use "was of no concern" at reported use levels, but set a temporary ADI and requested additional data (2018 re-evaluation).

The regulatory consensus holds that the animal studies raising concern either used degraded carrageenan (poligeenan), used concentrations not representative of human dietary exposure, or had methodological limitations.

The Degradation Question

One persistent scientific question is whether food-grade carrageenan can degrade into poligeenan during digestion or food processing. Regulatory bodies have consistently found that normal food processing and gastric conditions do not produce significant degradation of food-grade carrageenan to poligeenan.

International Status

European Union

Carrageenan and processed Eucheuma seaweed are authorized food additives in the EU:

• E407 — Carrageenan (refined extraction)
• E407a — Processed Eucheuma seaweed (semi-refined extraction)

Both are permitted in 79 food categories, often at quantum satis levels (no maximum use level).

Infant formula restriction: The EU prohibits or heavily restricts carrageenan use in infant formula.

EFSA 2018 Re-Evaluation: Concluded that intake of carrageenan and processed Eucheuma seaweed from food additive use was of no concern at reported use levels. However, the Panel set a temporary group ADI of 75 mg/kg bw/day and requested additional data within five years to address uncertainties, particularly regarding uses in food for young infants.

Ongoing re-evaluation (2024-2025): The European Commission has requested EFSA to address data gaps, with a specific focus on infant formula for infants below 16 weeks. Data submission deadline: November 25, 2025.

JECFA (Joint FAO/WHO Expert Committee on Food Additives)

• 1974: Established an ADI of 0-75 mg/kg bw/day.
• 1984: Changed ADI to "not specified" — the most favorable classification, reserved for substances of very low toxicity.
• 2015: Concluded that use in infant formula at concentrations up to 1,000 mg/L "is not of concern."

Other Jurisdictions

• Canada: Approved for food use
• Japan: Approved for food use
• Australia/New Zealand: Approved under FSANZ
• Codex Alimentarius: Listed as INS 407 with JECFA specifications

Affected Product Categories

Dairy:

• Chocolate milk, yogurt, ice cream, cream cheese, cottage cheese

Plant-Based Alternatives:

• Almond milk, soy milk, oat milk, vegan cheese, plant-based creamers

Processed Meats:

• Deli meats, hot dogs, canned meats (water binding, texture)

Infant Formula:

• Permitted in US; restricted in EU

Beverages:

• Nutritional shakes, protein drinks, juice blends

Confectionery:

• Gummies, marshmallows, jelly candies

Pet Food:

• Gravy and chunk-in-gravy canned formats

Market Dynamics

The global carrageenan market was valued at approximately $1.0 billion in 2024, with a projected CAGR of 6.6% through 2032. Dairy products remain the leading segment at 33.9% of market revenue.

A significant reformulation wave occurred between 2015-2022, driven by consumer pressure: WhiteWave Foods removed carrageenan from its Silk and Horizon Organic product lines, followed by Stonyfield, Organic Valley, and other major organic brands. Common replacements include gellan gum, locust bean gum, sunflower lecithin, and pectin, though none replicate carrageenan's full functional profile.

The market is now entering a recovery phase. Carrageenan's seaweed origin — requiring no land, no freshwater, no fertilizers, and actively sequestering carbon — positions it as a potentially "clean label" ingredient in sustainability-conscious markets, a reversal from its status five years ago.

State-Level Activity

No US state has enacted or introduced legislation to ban carrageenan. This distinguishes carrageenan from substances like Red No. 3, titanium dioxide, or potassium bromate, which have seen active state-level legislative action.

What Companies Should Do

No Immediate Compliance Changes Required

As of March 2026, carrageenan remains fully approved under 21 CFR 172.620 with no pending restrictions in any U.S. jurisdiction.

1. Maintain labeling compliance. Carrageenan must be declared by name on ingredient labels per FDA requirements. No special warnings are required.

2. Verify sourcing specifications. Ensure carrageenan suppliers meet 21 CFR 172.620 requirements (approved seaweed species, sulfate content 20-40% dry weight basis).

3. Monitor the NOSB sunset review. The 2026 sunset vote could again recommend delisting from the organic National List. If the USDA ultimately allows carrageenan to sunset, the deadline would be 2028, with implications for organic-certified products only.

4. Track the EFSA re-evaluation. If EFSA identifies safety concerns for infant formula use, this could influence FDA to re-examine its position.

5. Prepare consumer communications. Maintain clear documentation distinguishing food-grade carrageenan from poligeenan for consumer and retailer inquiries. The IARC Group 2B classification that drives media concern applies to a different substance.

Medium-Term Considerations

6. Evaluate the reformulation decision carefully. Removing carrageenan is currently a market-positioning choice, not a regulatory requirement. Weigh consumer perception against functional performance, cost, and sustainability positioning.

7. Monitor EU infant formula restrictions. Companies exporting infant formula to the EU should track the EFSA re-evaluation closely.

8. Watch organic market developments. The 2026 NOSB vote and USDA's response will determine whether organic-certified products can continue using carrageenan beyond 2028.

Regulatory Intelligence

Policy Canary tracks regulatory developments affecting carrageenan across FDA, USDA organic standards, EFSA re-evaluation, and state legislative activity. Subscribe to receive alerts when new regulatory actions affect this substance.

Carrageenan is not part of the FDA's food dye phase-out, California AB 418, or any state-level food additive ban. Do not conflate color additive or preservative regulatory actions with hydrocolloid/stabilizer regulatory status.